http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105535152-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate | 2015-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105535152-B |
titleOfInvention | Application of loquat leaf total sesquiterpene extract |
abstract | The invention discloses an application of a loquat leaf total sesquiterpene extract. More specifically, an application of a loquat leaf total sesquiterpene glycoside extract in preparing a medicament for treating hyperlipidemia and non-alcoholic fatty liver is disclosed, wherein the loquat leaf total sesquiterpene glycoside extract is prepared according to the patent 201410802741.1. The applicant finds that the loquat leaf total sesquiterpene extract can obviously improve lipid metabolism of type 2 diabetes mice, relieve degeneration and necrosis of liver cells of the type 2 diabetes mice, reduce lipid deposition and prevent the formation of non-alcoholic fatty liver on the basis of scientific experiments, and can be further researched and developed as a medicine or health-care product for treating hyperlipidemia and type 2 diabetes non-alcoholic fatty liver. |
priorityDate | 2015-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.